http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0135955-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1984-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1991-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1991-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0135955-B1 |
| titleOfInvention | Composition for the treatment of malignant tumours, particularly in animals |
| abstract | A therapy for the treatment of spontaneous malignant tumours, particularly in animals, comprises the conteporaneous separate administration of two products: the reduced beta-nicotinamin adenin dinucleotide (NADH2) and the pyridoxal-5-phosphate, respectively coenzymes of the cystine reductase and of the cysteine desulphidrase; the administration takes place initially once a day, than on alternate days in relation to the progressive regress of the tumour. |
| priorityDate | 1983-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.